688185 康希诺
已收盘 09-19 15:00:00
资讯
新帖
简况
康希诺(688185)：经营效率提高 流脑产品销售推进顺利
海通证券 · 09-13
康希诺(688185)：经营效率提高 流脑产品销售推进顺利
康希诺： 关于公司研发进展及对外合作情况等，请以公司公告为准
证券之星 · 09-11
康希诺： 关于公司研发进展及对外合作情况等，请以公司公告为准
康希诺09月09日主力资金流出91万元 连续3日减仓
市场透视 · 09-09
康希诺09月09日主力资金流出91万元 连续3日减仓
康希诺： 该临床试验为公司MCV4的扩龄相关研究
证券之星 · 09-06
康希诺： 该临床试验为公司MCV4的扩龄相关研究
康希诺09月03日主力资金流出499万元 连续5日减仓
市场透视 · 09-03
康希诺09月03日主力资金流出499万元 连续5日减仓
南向资金8月30日净买入康希诺生物10.64万股 连续3日增持
市场透视 · 09-02
南向资金8月30日净买入康希诺生物10.64万股 连续3日增持
中期核心指标持续优化，康希诺生物(6185.HK/688185.SH)驶入良性发展正轨
格隆汇 · 09-02
中期核心指标持续优化，康希诺生物(6185.HK/688185.SH)驶入良性发展正轨
康希诺（688185）2024年中报简析：营收上升亏损收窄，盈利能力上升
证券之星 · 08-31
康希诺（688185）2024年中报简析：营收上升亏损收窄，盈利能力上升
康希诺(688185)：业绩符合预期 PCV13即将获批
中金公司 · 08-31
康希诺(688185)：业绩符合预期 PCV13即将获批
破发股康希诺两年一期亏损 2020年上市募52亿元
中国经济网 · 08-30
破发股康希诺两年一期亏损 2020年上市募52亿元
康希诺股价大幅上涨 获融资净买入78万元
智选洞察 · 08-30
康希诺股价大幅上涨 获融资净买入78万元
生物制品行业盘中拉升，康希诺涨3.97%
市场透视 · 08-30
生物制品行业盘中拉升，康希诺涨3.97%
图解康希诺中报：第二季度单季净利润同比增92.12%
证券之星 · 08-30
图解康希诺中报：第二季度单季净利润同比增92.12%
康希诺(688185.SH)发布半年度业绩，净亏损2.25亿元
智通财经 · 08-29
康希诺(688185.SH)发布半年度业绩，净亏损2.25亿元
康希诺生物公布中期业绩 公司所有者应占亏损约2.25亿元 同比收窄73.22%
智通财经 · 08-29
康希诺生物公布中期业绩 公司所有者应占亏损约2.25亿元 同比收窄73.22%
康希诺上半年营收3.03亿元同比增1071.20%，净利润-2.25亿元同比增73.22%，研发费用
新浪财经 · 08-29
康希诺上半年营收3.03亿元同比增1071.20%，净利润-2.25亿元同比增73.22%，研发费用
【康希诺：2024年上半年净利润亏损2.25亿】金十数据8月29日讯，康希诺生物(06185.HK)公告，2024年上半年公司实现营业收入3.
美港电讯 · 08-29
【康希诺：2024年上半年净利润亏损2.25亿】金十数据8月29日讯，康希诺生物(06185.HK)公告，2024年上半年公司实现营业收入3.
康希诺（688185）8月28日主力资金净卖出416.24万元
证券之星 · 08-29
康希诺（688185）8月28日主力资金净卖出416.24万元
A股疫苗股震荡走低，金迪克跌超10%，康希诺、华兰疫苗、蔚蓝生物、百克生物、博晖创新等跟跌。
美港电讯 · 08-28
A股疫苗股震荡走低，金迪克跌超10%，康希诺、华兰疫苗、蔚蓝生物、百克生物、博晖创新等跟跌。
康希诺（688185）8月27日主力资金净买入1425.97万元
证券之星 · 08-28
康希诺（688185）8月27日主力资金净买入1425.97万元
暂无数据
公司概况
公司名称：
康希诺生物股份公司
所属行业：
医药制造业
上市日期：
2020-08-13
主营业务：
康希诺生物股份公司的主营业务是研发、生产和商业化符合中国及国际标准的创新型疫苗。公司主要产品为埃博拉病毒病疫苗、脑膜炎疫苗、百白破疫苗、肺炎疫苗、结核病疫苗、带状疱疹疫苗、新冠肺炎疫苗、腺病毒疫苗、脊髓灰质炎疫苗。公司获得了“天津瞪羚企业卓越创新奖”、“中国最具成长力科技创新型医药企业”、“天津市呼吸道细菌重组及结合疫苗企业重点实验室”等多项荣誉。
发行价格：
209.71
{"stockData":{"symbol":"688185","market":"SH","secType":"STK","nameCN":"康希诺","latestPrice":41,"timestamp":1726729200000,"preClose":41.26,"halted":0,"volume":1475232,"delay":0,"floatShares":114999999,"shares":247000000,"eps":-3.5025,"marketStatus":"已收盘","marketStatusCode":5,"change":-0.26,"latestTime":"09-19 15:00:00","open":41.57,"high":41.68,"low":40.68,"amount":60774100,"amplitude":0.0242,"askPrice":41.03,"askSize":4,"bidPrice":41,"bidSize":35,"shortable":0,"etf":0,"ttmEps":-3.5025,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1726795800000},"adr":0,"adjPreClose":41.26,"symbolType":"stock_kcb","openAndCloseTimeList":[[1726709400000,1726716600000],[1726722000000,1726729200000]],"highLimit":45.39,"lowLimit":37.13,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":247449899,"pbRate":2.01,"roa":"--","roe":"--","epsLYR":-6.01,"committee":0.259843,"marketValue":10145000000,"floatMarketCap":4706000000,"peRate":-11.705924,"changeRate":-0.0063,"turnoverRate":0.0129,"status":1,"afterMarket":{"amount":0,"volume":0,"close":41,"buyVolume":0,"sellVolume":300,"time":1726731237153,"indexStatus":"已收盘 09-19 15:30:00","preClose":41.26}},"requestUrl":"/m/hq/s/688185/tweets","defaultTab":"tweets","newsList":[{"id":"2467757929","title":"康希诺(688185)：经营效率提高 流脑产品销售推进顺利","url":"https://stock-news.laohu8.com/highlight/detail?id=2467757929","media":"海通证券","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2467757929?lang=zh_cn&edition=full","pubTime":"2024-09-13 00:00","pubTimestamp":1726156800,"startTime":"0","endTime":"0","summary":"公司营业收入增加的主要原因是报告期内流脑疫苗产品的推广和市场导入持续推进，同时加大了CDMO 及其他服务工作。公司费用管控及整体经营效率提高。24Q2，公司销售费用0.66 亿元，销售费用率34.84%；管理费用0.46 亿元，管理费用率24.55%；研发费用0.89 亿元，研发费用率47.14%。流脑产品销售收入同比增长18%，市场导入持续推进。2024 年上半年，公司两款流脑结合疫苗实现销售收入约2.6 亿元，去年同期为2.2 亿元，同比增长约18.00%。管线研发推进顺利。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202409130841189ef91435&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202409130841189ef91435&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0239","688185"],"gpt_icon":0},{"id":"2466404728","title":"康希诺：\n关于公司研发进展及对外合作情况等，请以公司公告为准","url":"https://stock-news.laohu8.com/highlight/detail?id=2466404728","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2466404728?lang=zh_cn&edition=full","pubTime":"2024-09-11 19:02","pubTimestamp":1726052574,"startTime":"0","endTime":"0","summary":"谢谢康希诺董秘：尊敬的投资人您好，关于公司研发进展及对外合作情况等，请以公司公告为准。康希诺董秘：尊敬的投资人您好，根据中国证券登记结算有限责任公司下发的公司2024年9月10日A股股东名册，持有人数为19989人。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024091100033550.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688185"],"gpt_icon":0},{"id":"2466982137","title":"康希诺09月09日主力资金流出91万元 连续3日减仓","url":"https://stock-news.laohu8.com/highlight/detail?id=2466982137","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2466982137?lang=zh_cn&edition=full","pubTime":"2024-09-09 15:19","pubTimestamp":1725866369,"startTime":"0","endTime":"0","summary":"09月09日, 康希诺股价跌1.05%，报收38.70元，成交金额3211万元，换手率0.72%，振幅2.53%，量比0.76。康希诺今日主力资金净流出91万元，连续3日净流出，上一交易日主力净流出142万元，今日环比减少35.92%。近一年数据显示，该股主力连续3日净流出后，次日下跌概率为62.50%，平均跌幅为2.21%。该股近5个交易日下跌1.53%，主力资金累计净流出648万元，其中2个交易日为股价上涨时净流出；近20日主力资金累计净流出464万元，其中净流出天数为13日。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202409091535039eee1897&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202409091535039eee1897&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688185","BK0239"],"gpt_icon":0},{"id":"2465616276","title":"康希诺：\n该临床试验为公司MCV4的扩龄相关研究","url":"https://stock-news.laohu8.com/highlight/detail?id=2465616276","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2465616276?lang=zh_cn&edition=full","pubTime":"2024-09-06 18:04","pubTimestamp":1725617068,"startTime":"0","endTime":"0","summary":"证券之星消息，康希诺09月06日在投资者关系平台上答复投资者关心的问题。康希诺董秘：尊敬的投资人您好，该临床试验为公司MCV4的扩龄相关研究。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024090600030120.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688185","BK1576","BK0239","BK1141","BK1583","03347"],"gpt_icon":0},{"id":"2464239508","title":"康希诺09月03日主力资金流出499万元 连续5日减仓","url":"https://stock-news.laohu8.com/highlight/detail?id=2464239508","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2464239508?lang=zh_cn&edition=full","pubTime":"2024-09-03 15:18","pubTimestamp":1725347935,"startTime":"0","endTime":"0","summary":"09月03日, 康希诺股价涨1.50%，报收39.89元，成交金额4433万元，换手率0.97%，振幅3.44%，量比0.59。康希诺今日主力资金净流出499万元，连续5日净流出，上一交易日主力净流出481万元，今日环比增加3.74%。近一年数据显示，该股主力连续5日净流出后，次日下跌概率为60.00%，平均跌幅为2.48%。该股近5个交易日上涨2.89%，主力资金累计净流出3032万元；近20日主力资金累计净流入1326万元，其中净流入天数为10日。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024090315344995de4fc1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024090315344995de4fc1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688185","BK0239"],"gpt_icon":0},{"id":"2464218330","title":"南向资金8月30日净买入康希诺生物10.64万股 连续3日增持","url":"https://stock-news.laohu8.com/highlight/detail?id=2464218330","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2464218330?lang=zh_cn&edition=full","pubTime":"2024-09-02 09:30","pubTimestamp":1725240618,"startTime":"0","endTime":"0","summary":"8月30日, 南向资金增持康希诺生物10.64万股，连续3日增持。截止当日收盘，港股通共持有康希诺生物4928.38万股，占流通股37.14%。康希诺生物近5个交易日上涨11.34%，港股通累计增持0.40万股；近20个交易日下跌2.04%，港股通累计增持45.96万股。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024090209322895da5cfb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024090209322895da5cfb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688185","BK0239","06185"],"gpt_icon":0},{"id":"2464776025","title":"中期核心指标持续优化，康希诺生物(6185.HK/688185.SH)驶入良性发展正轨","url":"https://stock-news.laohu8.com/highlight/detail?id=2464776025","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2464776025?lang=zh_cn&edition=full","pubTime":"2024-09-02 08:46","pubTimestamp":1725237994,"startTime":"0","endTime":"0","summary":"上半年，康希诺的各项业绩指标持续改善，逐步摆脱了前期公共卫生事件的影响，迈向了良性发展的轨道。","market":"sg","thumbnail":"https://img7.gelonghui.com/column/2/110.png","type":0,"news_type":0,"thumbnails":["https://img7.gelonghui.com/column/2/110.png"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.gelonghui.com/p/986671","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"gelonghui_highlight","symbols":["688185","BK0239","BK1191","BK1161","BK1515","BK1574","06185"],"gpt_icon":0},{"id":"2463715694","title":"康希诺（688185）2024年中报简析：营收上升亏损收窄，盈利能力上升","url":"https://stock-news.laohu8.com/highlight/detail?id=2463715694","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2463715694?lang=zh_cn&edition=full","pubTime":"2024-08-31 06:17","pubTimestamp":1725056268,"startTime":"0","endTime":"0","summary":"据证券之星公开数据整理，近期康希诺发布2024年中报。截至本报告期末，公司营业总收入3.03亿元，同比上升1071.2%，归母净利润-2.25亿元，同比上升73.22%。本报告期康希诺盈利能力上升，毛利率同比增幅129.4%，净利率同比增幅98.47%。以上内容为证券之星据公开信息整理，由智能算法生成，不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024083100008480.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688185"],"gpt_icon":0},{"id":"2463744234","title":"康希诺(688185)：业绩符合预期 PCV13即将获批","url":"https://stock-news.laohu8.com/highlight/detail?id=2463744234","media":"中金公司","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2463744234?lang=zh_cn&edition=full","pubTime":"2024-08-31 00:00","pubTimestamp":1725033600,"startTime":"0","endTime":"0","summary":"1H24 业绩符合我们预期公司公布1H24 业绩：收入3.03 亿元，同比增长1,071.2%；归母净亏损2.25亿元，业绩符合我们预期。发展趋势MCV4 稳步增长。MCV4 是公司未来2 年的重点推广产品，考虑到该产品市场独占期尚有2 年，我们看好该产品未来销售前景。此外，公司已启动MCV4 的出海工作，主要目标区域包括东南亚、中东、北非、南美等。我们预计公司全年仍将维持费用控制的策略。风险商业化不及预期；研发进展不及预期。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408311126289f6b2ebe&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408311126289f6b2ebe&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688185","BK0239"],"gpt_icon":0},{"id":"2463270813","title":"破发股康希诺两年一期亏损 2020年上市募52亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2463270813","media":"中国经济网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2463270813?lang=zh_cn&edition=full","pubTime":"2024-08-30 14:34","pubTimestamp":1724999640,"startTime":"0","endTime":"0","summary":" 康希诺于2020年8月13日在上交所科创板上市，发行数量为2480万股，发行价格209.71元/股，保荐机构为中信证券，保荐代表人为焦延延、马可；联席主承销商为中金公司，副主承销商为渤海证券。 康希诺募集资金总额为52.01亿元，扣除发行费用后，募集资金净额为49.79亿元。康希诺最终募集资金净额较原计划多39.79亿元。 康希诺上市发行费用为2.21亿元，其中保荐及承销费用2.05亿元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/roll/2024-08-30/doc-incmmeze3441585.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/roll/2024-08-30/doc-incmmeze3441585.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK0239","688185"],"gpt_icon":0},{"id":"2463727612","title":"康希诺股价大幅上涨 获融资净买入78万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2463727612","media":"智选洞察","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2463727612?lang=zh_cn&edition=full","pubTime":"2024-08-30 13:04","pubTimestamp":1724994265,"startTime":"0","endTime":"0","summary":"08月30日，康希诺股价大幅上涨，截至13点04分，康希诺上涨5.02%，报41.00元/股，突破40元整数关口，成交6656万元，换手率1.44%，振幅3.97%。资金动向截止发稿，康希诺获得主力净流出708万元，其中超大单流出596万元，大单流出110万元。融资融券方面，康希诺08月29日获得融资净买入78万元，当日该股融资余额为2.94亿元，当较前一日增加0.27%；该股融券余额为52万元，融券余量为1.28万股，比上日增加1.59%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240830131034a1d77d1d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240830131034a1d77d1d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688185","BK0239"],"gpt_icon":0},{"id":"2463051247","title":"生物制品行业盘中拉升，康希诺涨3.97%","url":"https://stock-news.laohu8.com/highlight/detail?id=2463051247","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2463051247?lang=zh_cn&edition=full","pubTime":"2024-08-30 09:47","pubTimestamp":1724982478,"startTime":"0","endTime":"0","summary":"08月30日，生物制品行业盘中拉升，截至09点47分，生物制品行业整体指数上涨0.51%，报5424.430点。从个股上来看，该行业的成分股中，康希诺涨3.97%，诺唯赞、君实生物-U、荣昌生物涨幅居前。从资金上来看，截止发稿，生物制品行业主力净流入为-2141.92万，其中长春高新受到资金热捧，主力净流入577.47万；拉长时间线来看，该板块近20日主力资金净流入-20.27亿。（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。股市有风险，请谨慎决策。）","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240830094758942016fc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240830094758942016fc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["06185","688185","BK0239"],"gpt_icon":0},{"id":"2463529592","title":"图解康希诺中报：第二季度单季净利润同比增92.12%","url":"https://stock-news.laohu8.com/highlight/detail?id=2463529592","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2463529592?lang=zh_cn&edition=full","pubTime":"2024-08-30 02:07","pubTimestamp":1724954860,"startTime":"0","endTime":"0","summary":"证券之星消息，康希诺2024年中报显示，公司主营收入3.03亿元，同比上升1071.2%；归母净利润-2.25亿元，同比上升73.22%；扣非净利润-2.55亿元，同比上升71.22%；其中2024年第二季度，公司单季度主营收入1.89亿元，同比上升353.4%；单季度归母净利润-5527.8万元，同比上升92.12%；单季度扣非净利润-7584.94万元，同比上升89.24%；负债率37.8%，投资收益-6439.3万元，财务费用-2126.98万元，毛利率69.86%。财报数据概要请见下图: 以上内容为证券之星据公开信息整理，由智能算法生成，不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024083000003193.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688185"],"gpt_icon":0},{"id":"2463252459","title":"康希诺(688185.SH)发布半年度业绩，净亏损2.25亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2463252459","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2463252459?lang=zh_cn&edition=full","pubTime":"2024-08-29 22:08","pubTimestamp":1724940506,"startTime":"0","endTime":"0","summary":"智通财经APP讯，康希诺(688185.SH)披露2024年半年度报告，报告期公司实现营收3.03亿元，同比增长1071.2%;归母净利润亏损2.25亿元，同比收窄;扣非净利润亏损2.55亿元，同比收窄;基本每股收益-0.91元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1175688.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1191","BK1515","BK1574","688185","06185","BK1161","BK0239"],"gpt_icon":0},{"id":"2463525155","title":"康希诺生物公布中期业绩 公司所有者应占亏损约2.25亿元 同比收窄73.22%","url":"https://stock-news.laohu8.com/highlight/detail?id=2463525155","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2463525155?lang=zh_cn&edition=full","pubTime":"2024-08-29 21:03","pubTimestamp":1724936582,"startTime":"0","endTime":"0","summary":"康希诺生物公布2024年中期业绩，收入约2.85亿元，同比增长1253.6%;毛利约人民币1.87亿元，去年同期毛损约7.765亿元;研发开支约1.86亿元，同比减少45.1%;公司所有者应占期内亏损约2.25亿元，同比收窄73.22%;每股亏损0.91元。流脑疫苗产品销售增加乃主要由于推进流脑疫苗产品商业化所致。公司正在寻求业务多元化，并于报告期内取得CDMO收入约2260万元。于报告期，公司流脑结合疫苗实现了销售收入约2.63亿元，较去年同期增长18.0%，为公司稳定发展做出了贡献。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024082921165095d00df0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024082921165095d00df0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688185","BK0239"],"gpt_icon":0},{"id":"2463634258","title":"康希诺上半年营收3.03亿元同比增1071.20%，净利润-2.25亿元同比增73.22%，研发费用","url":"https://stock-news.laohu8.com/highlight/detail?id=2463634258","media":"新浪财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2463634258?lang=zh_cn&edition=full","pubTime":"2024-08-29 20:31","pubTimestamp":1724934661,"startTime":"0","endTime":"0","summary":"8月29日， 康希诺 发布2024年半年报。根据半年报，康希诺第二季度实现营业总收入1.89亿元，同比增长353.40%，环比增长65.51%；归母净利润-5527.80万元，同比增长92.12%，环比增长67.50%；扣非净利润-7584.94万元，同比增长89.38%，环比增长57.55%。2024年上半年，公司毛利率为69.86%，同比上升307.49个百分点；净利率为-75.85%，较上年同期上升4873.12个百分点。其中，销售费用同比减少12.70%，管理费用同比减少38.45%，研发费用同比减少45.06%，财务费用同比增长64.01%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024082920413495cff8eb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024082920413495cff8eb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["06185","688185"],"gpt_icon":0},{"id":"2463871352","title":"【康希诺：2024年上半年净利润亏损2.25亿】金十数据8月29日讯，康希诺生物(06185.HK)公告，2024年上半年公司实现营业收入3.","url":"https://stock-news.laohu8.com/highlight/detail?id=2463871352","media":"美港电讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2463871352?lang=zh_cn&edition=full","pubTime":"2024-08-29 18:11","pubTimestamp":1724926297,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.ushknews.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_meigang","symbols":["BK1515","BK1161","159646","BK4139","BK1574","CDMO","688185","BK0239","BK1191","06185"],"gpt_icon":0},{"id":"2463447212","title":"康希诺（688185）8月28日主力资金净卖出416.24万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2463447212","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2463447212?lang=zh_cn&edition=full","pubTime":"2024-08-29 08:26","pubTimestamp":1724891214,"startTime":"0","endTime":"0","summary":"证券之星消息，截至2024年8月28日收盘，康希诺报收于38.3元，下跌1.21%，换手率1.04%，成交量1.2万手，成交额4558.86万元。近5日资金流向一览见下表：康希诺融资融券信息显示，融资方面，当日融资买入302.48万元，融资偿还547.35万元，融资净偿还244.87万元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024082900009490.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688185"],"gpt_icon":0},{"id":"2462717504","title":"A股疫苗股震荡走低，金迪克跌超10%，康希诺、华兰疫苗、蔚蓝生物、百克生物、博晖创新等跟跌。","url":"https://stock-news.laohu8.com/highlight/detail?id=2462717504","media":"美港电讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2462717504?lang=zh_cn&edition=full","pubTime":"2024-08-28 09:45","pubTimestamp":1724809504,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.ushknews.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_meigang","symbols":["603739","BK0048","BK0226","BK0028","688185","688670","BK0251","399300","301207","688276","159982","300318","159646","BK0239"],"gpt_icon":0},{"id":"2462122835","title":"康希诺（688185）8月27日主力资金净买入1425.97万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2462122835","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2462122835?lang=zh_cn&edition=full","pubTime":"2024-08-28 08:12","pubTimestamp":1724803922,"startTime":"0","endTime":"0","summary":"证券之星消息，截至2024年8月27日收盘，康希诺报收于38.77元，上涨3.77%，换手率2.35%，成交量2.69万手，成交额1.05亿元。近5日资金流向一览见下表：康希诺融资融券信息显示，融资方面，当日融资买入1238.28万元，融资偿还732.34万元，融资净买入505.94万元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024082800009813.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688185"],"gpt_icon":0}],"profile":{"ret":0,"listingDate":"2020-08-13","address":"天津市东丽区经济技术开发区西区南大街185号西区生物医药园四层401-420","stockEarnings":[{"period":"1week","weight":0.0403},{"period":"1month","weight":-0.006},{"period":"3month","weight":-0.0497},{"period":"6month","weight":-0.2212},{"period":"1year","weight":-0.4616},{"period":"ytd","weight":-0.4463}],"companyName":"康希诺生物股份公司","boardCode":"AI0027","perCapita":"5742股","boardName":"医药制造业","registeredCapital":"24744万元","compareEarnings":[{"period":"1week","weight":-0.0017},{"period":"1month","weight":-0.061},{"period":"3month","weight":-0.0959},{"period":"6month","weight":-0.1085},{"period":"1year","weight":-0.1305},{"period":"ytd","weight":-0.0866}],"survey":" 康希诺生物股份公司的主营业务是研发、生产和商业化符合中国及国际标准的创新型疫苗。公司主要产品为埃博拉病毒病疫苗、脑膜炎疫苗、百白破疫苗、肺炎疫苗、结核病疫苗、带状疱疹疫苗、新冠肺炎疫苗、腺病毒疫苗、脊髓灰质炎疫苗。公司获得了“天津瞪羚企业卓越创新奖”、“中国最具成长力科技创新型医药企业”、“天津市呼吸道细菌重组及结合疫苗企业重点实验室”等多项荣誉。","serverTime":1726760147507,"listedPrice":209.71,"stockholders":"19989人(较上一季度减少0.88%)","compareStock":{"symbol":"000001.SH","name":"上证指数"}},"APP":{"userAgent":"CCBot/2.0 (https://commoncrawl.org/faq/)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.26.4","shortVersion":"4.26.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"康希诺(688185)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供康希诺(688185)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"康希诺,688185,康希诺股票,康希诺股票老虎,康希诺股票老虎国际,康希诺行情,康希诺股票行情,康希诺股价,康希诺股市,康希诺股票价格,康希诺股票交易,康希诺股票购买,康希诺股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"康希诺(688185)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供康希诺(688185)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}